Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesAdagio Medical Holdings, Inc Common Stock

Adagio Medical Holdings, Inc Common Stock

Healthcare Medical Devices
PortfolioPortfolio WatchlistWatchlist
Company price
0.0649 USD 0.00(0%)
Last update at 2026-11-06T21:00:00Z
VOLUME
1196853
Market Cap
10.26M

Momentum Score

…

Adagio Medical Holdings, Inc., a medical technology company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature ablation (ULTA) catheter and system; vCLAS ventricular ULTC catheter; and Cryopulse pulsed field cryoablation catheters. Adagio Medical Holdings, Inc. was founded in 2011 and is headquartered in Laguna Hills, California.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.06
Low
0.07
High
52 Week Price Range
0.36
Low
2.58
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Publicly available information on Adagio Medical Holdings, Inc. (NASDAQ: ADGM) is limited; company filings describe it as a healthcare/medical technology company but detailed product portfolio, commercial status and market positioning are not clearly described in widely accessible sources. Long-term growth appears to depend on successful development and market adoption of any proprietary therapies or devices, which could support revenue expansion if execution and clinical outcomes are favorable.
Key investment risks include limited disclosure and transparency about operations, potential liquidity and financing needs typical of small-cap companies, and sensitivity to investor sentiment and share-price volatility.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.06
Dividend Yield
-
Revenue TTM
0.14M
Revenue Per Share
0.01
Gross Profit TTM
-0.09M
Debt / Equity
1.75
ROE
-657.76%
Net Debt
4.65M
ROCE
-62.51%
Diluted EPS TTM
-1.37

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -25.08M -53.76M -38.15M 1.07M -6.56M
Net income -25.08M -53.76M -38.15M 1.07M -6.56M
Selling general administrative 10.57M - 4.75M 1.01M 6.61M
Selling and marketing expenses - - 6.78M - -
Gross profit -0.68M -1.67M -1.01M -0.69M -0.89M
Reconciled depreciation 0.97M - 0.53M 0.49M 0.34M
Ebit - -54.87M -27.94M -21.34M -19.55M
Ebitda -21.89M -62.48M -27.41M -23.42M -19.60M
Depreciation and amortization - -7.61M 0.53M -2.08M -0.05M
Operating income -21.89M -62.48M -27.94M -1.01M -6.61M
Other operating expenses 21.89M 62.75M 28.24M 1.01M 6.61M
Interest expense 2.91M 1.10M 1.66M 0.14M 0.00M
Interest income 0.48M - 0.00M 0.04M 0.00M
Net interest income -2.43M - -1.66M -0.10M 0.00M
Income tax expense - -53.76M - - -
Total revenue 0.00M 0.27M 0.30M 0.19M 0.27M
Total operating expenses 21.21M 60.81M 26.94M 1.01M 6.61M
Cost of revenue 0.68M 1.94M 1.31M 0.88M 1.16M
Total other income expense net -3.19M 8.72M -10.20M 0.24M 14.08M
Net income from continuing ops -25.08M - -38.15M -23.67M -19.94M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 43.25M 48.45M 6.83M 151.78M 150.42M
Intangible assets 6.97M 6.97M - - -
Other current assets 1.30M 2.16M 0.41M 0.82M 0.50M
Total liab 30.85M 28.54M 48.94M 8.89M 11.22M
Total stockholder equity 12.40M 19.91M -42.11M 142.89M 139.20M
Other current liab 7.00M 4.78M 5.14M 11.67M 5.41M
Common stock 0.00M 0.00M 0.00M 151.53M 149.50M
Capital stock 0.00M 0.00M 0.00M 0.00M 0.00M
Retained earnings -95.61M -70.59M -135.21M -8.64M -10.30M
Good will 13.97M 13.97M - - -
Other assets - -1.75M - - -
Cash 17.11M 20.59M 1.38M 0.09M 0.50M
Total current liabilities 8.23M 7.76M 48.73M 6.27M 5.99M
Net debt 4.65M -4.32M 38.57M 0.03M -0.50M
Short term debt 0.15M 0.14M 39.76M 0.28M -
Short long term debt - - 39.68M 9.50M -
Short long term debt total 21.76M 16.27M 39.95M 0.12M -
Other stockholder equity 108.11M 90.50M 93.08M 92.62M 63.09M
Total current assets 20.08M 25.35M 5.18M 0.15M 0.87M
Short term investments - - 1.36M - -
Net receivables 0.00M 0.04M 0.07M -6.59M 0.03M
Long term debt 21.04M 16.08M 0.14M - -
Inventory 1.67M 2.57M 3.32M 0.37M 0.33M
Accounts payable 1.08M 2.84M 3.83M 1.01M 0.58M
Accumulated other comprehensive income -0.10M 0.00M 0.02M 0.03M 0.00M
Non currrent assets other 0.00M 0.01M 0.02M 149.69M 147.85M
Non current assets total 23.17M 23.10M 1.64M 151.63M 149.55M
Capital lease obligations 0.72M 0.19M 0.13M 0.30M 0.00M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - - -0.34M -0.50M -1.27M
Total cashflows from investing activities -0.37M -1.65M - - -
Net borrowings 0.00M - - - -
Total cash from financing activities 16.13M 15.63M 21.88M 0.07M 151.07M
Net income -25.08M -75.04M -38.15M 1.07M -6.56M
Change in cash -3.48M 20.57M -4.16M -0.41M -38.73M
Begin period cash flow 20.59M 0.02M 5.55M 0.50M 39.23M
End period cash flow 17.11M 20.59M 1.38M 0.09M 0.50M
Total cash from operating activities -19.01M -29.46M -25.65M -0.49M -1.07M
Issuance of capital stock 16.13M - - - -
Depreciation 0.97M 1.39M 0.53M 0.49M 0.34M
Other cashflows from investing activities -0.37M -1.28M - - -
Change to inventory 0.93M 0.63M -2.98M 0.04M -0.47M
Change to account receivables 0.04M 0.04M -0.07M 0.03M 0.04M
Sale purchase of stock - - -115.07M - -
Other cashflows from financing activities 16.13M 15.63M 0.02M 9.45M -149.50M
Capital expenditures 0.37M 1.65M 0.34M 0.50M 1.27M
Change in working capital 2.66M 5.79M 2.79M 0.52M 5.54M
Stock based compensation 1.48M 0.64M 0.44M 0.36M 0.34M
Other non cash items -21.68M 40.33M 8.73M -2.08M -0.05M
Free cash flow -19.39M -31.11M -25.99M -0.99M -2.34M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
ADGM
Adagio Medical Holdings, Inc Common Stock		 -
-%		 0.06 - - 205.85 2.89 370.25
ABT
Abbott Laboratories		 -0.03
0.03%		 109.93 25.97 17.24 3.57 3.20 3.81
MDT
Medtronic PLC		 -3.04
2.90%		 101.80 26.60 15.87 3.35 2.08 3.90
SYK
Stryker Corporation		 -9.21
2.75%		 325.87 29.23 16.86 4.18 4.51 4.63
SEMHF
Siemens Healthineers AG		 -2.15
4.12%		 49.85 39.57 21.32 3.01 3.29 2.95

Profile*

Adagio Medical Holdings, Inc Common Stock

Adagio Medical Holdings, Inc., a medical technology company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature ablation (ULTA) catheter and system; vCLAS ventricular ULTC catheter; and Cryopulse pulsed field cryoablation catheters. Adagio Medical Holdings, Inc. was founded in 2011 and is headquartered in Laguna Hills, California.

26051 Merit Circle, Laguna Hills, CA, United States, 92653

949 348 1188

https://adagiomedical.com

41

Name Title Year Born
Mr. Olav B. Bergheim Chairman & CEO 1950
Mr. John T. Dahldorf Chief Financial Officer 1957
Mr. Hakon Bergheim Chief Operating Officer 1982
Dr. Alex Babkin Ph.D. Chief Technical Officer NA
Mr. Nabil Jubran Chief Compliance Officer NA
Mr. Ilya Grigorov Vice President of Global Marketing & Product Management NA
Mr. Todd Usen CEO & Director 1967
Ms. Deborah Kaster CFO & Chief Business Officer 1970
Mr. Antwan Gipson M.B.A. Senior Vice President of Manufacturing & Operations NA
Ms. Marie-Claude Jacques Senior Vice President of Global Sales 1985

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

ITH
CAD 2.15
+27.68%
HG
CAD 4.11
+19.13%
PPTA
CAD 27.74
+17.99%
UCU
CAD 2.10
+17.32%
GAU
CAD 3.49
+16.72%
TSU
CAD 29.67
-29.71%
PXT
CAD 19.73
-16.91%
LAS-A
CAD 230.50
-9.25%
IFP
CAD 13.50
-8.35%
NFI
CAD 24.01
-7.80%

Equity Sectors*

  • Basic Materials

    +3.74%

  • Communication Services

    +0.56%

  • Consumer Cyclical

    -0.34%

  • Consumer Defensive

    +0.11%

  • Energy

    +1.33%

  • Financial Services

    -0.26%

  • Healthcare

    +2.54%

  • Industrials

    -0.11%

  • Real Estate

    -0.23%

  • Technology

    +1.91%

  • Utilities

    +1.05%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…